{
    "title": "A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11265305/A-Chinese-mRNA-COVID-vaccine-gains-approval--Indonesia.html",
    "date": "2022-09-30",
    "keywords": [
        "vaccine",
        "indonesia",
        "walvax",
        "awcorna",
        "use",
        "country",
        "mrna",
        "coronavirus",
        "china",
        "efficacy",
        "omicron",
        "variant",
        "shot",
        "covid",
        "stanley",
        "widianto",
        "roxanne",
        "liu",
        "emergency",
        "approval",
        "company",
        "agency",
        "development",
        "strain",
        "latestage",
        "westernmade",
        "ltd",
        "abogen",
        "covid19",
        "food",
        "biotechnology",
        "co",
        "ltds",
        "somewhat",
        "surprise",
        "mexico",
        "risk",
        "head",
        "comment",
        "share",
        "reaction",
        "stock",
        "pandemic",
        "supply",
        "candidate",
        "population",
        "health",
        "world",
        "bivalent",
        "pfizer",
        "biontech",
        "se",
        "life",
        "ideal",
        "archipelago",
        "bpom",
        "storage",
        "booster",
        "firm",
        "etana",
        "production",
        "capacity",
        "year",
        "spokesperson",
        "lusy",
        "andriani",
        "epidemiologist",
        "australias",
        "griffith",
        "university",
        "home",
        "technology",
        "transfer",
        "expertise",
        "institution",
        "suzhou",
        "target",
        "part",
        "portfolio",
        "reporting",
        "jakarta",
        "editing",
        "miyoung",
        "gibbs",
        "jonathan",
        "oatis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}